Table 1.
Groups | EDV (mm) | ESV (mm) | Increase rate of thickness of LVAW |
---|---|---|---|
Normal control | 3.338 ± 0.22 | 4.954 ± 0.62 | 0.484 ± 0.01 |
MSC 3 days | 3.293 ± 0.15 | 4.248 ± 0.17 | 0.290 ± 0.02* |
G-CSF 3 days | 3.278 ± 0.36 | 4.195 ± 0.23 | 0.280 ± 0.01* |
MSC + G-CSF 3 days | 3.320 ± 0.28 | 4.343 ± 0.43 | 0.308 ± 0.06* |
PBS 3 days | 3.252 ± 0.44 | 4.122 ± 0.14 | 0.268 ± 0.03* |
MSC 7 days | 3.322 ± 0.15 | 4.517 ± 0.25 | 0.362 ± 0.01*,#,&, % |
G-CSF 7 days | 3.305 ± 0.37 | 4.480 ± 0.38 | 0.351 ± 0.03*,#,&, % |
MSC + G-CSF 7 days | 3.330 ± 0.13 | 4.665 ± 0.21 | 0.401 ± 0.02*,#, % |
PBS 7 days | 3.282 ± 0.41 | 4.178 ± 0.36 | 0.273 ± 0.03* |
EDV end-diastolic volume, ESV end-systolic volume, LVAW left ventricular anterior wall; Data were expressed as mean ± SD
* P < 0.05, compared with normal control
# P < 0.05, compared with PBS group
& P < 0.05, compared with MSC + G-CSF group
% P < 0.05, compared with corresponding treatment groups at 3 days